vs
LCNB CORP（LCNB）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
LCNB CORP的季度营收约是ROCKWELL MEDICAL, INC.的1.3倍（$23.9M vs $18.3M），LCNB CORP净利率更高（23.7% vs -3.0%，领先26.7%），LCNB CORP同比增速更快（5.1% vs -25.6%），LCNB CORP自由现金流更多（$33.4M vs $2.2M），过去两年LCNB CORP的营收复合增速更高（15.7% vs -10.1%）
LCNB集团是总部位于美国的金融控股公司，通过旗下附属国民银行开展业务，主要为俄亥俄州区域市场的个人消费者、中小企业及本地社区机构提供零售与商业银行产品、财富管理及保险相关服务。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
LCNB vs RMTI — 直观对比
营收规模更大
LCNB
是对方的1.3倍
$18.3M
营收增速更快
LCNB
高出30.7%
-25.6%
净利率更高
LCNB
高出26.7%
-3.0%
自由现金流更多
LCNB
多$31.2M
$2.2M
两年增速更快
LCNB
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.9M | $18.3M |
| 净利润 | $5.7M | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | 29.2% | -2.2% |
| 净利率 | 23.7% | -3.0% |
| 营收同比 | 5.1% | -25.6% |
| 净利润同比 | -7.6% | 26.7% |
| 每股收益（稀释后） | $0.40 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LCNBRMTI
| Q4 25 | $23.9M | $18.3M | ||
| Q3 25 | $23.8M | $15.9M | ||
| Q2 25 | $22.8M | $16.1M | ||
| Q1 25 | $21.5M | $18.9M | ||
| Q4 24 | $22.7M | $24.7M | ||
| Q3 24 | $21.4M | $28.3M | ||
| Q2 24 | $19.3M | $25.8M | ||
| Q1 24 | $17.8M | $22.7M |
净利润LCNBRMTI
| Q4 25 | $5.7M | $-554.0K | ||
| Q3 25 | $6.9M | $-1.8M | ||
| Q2 25 | $5.9M | $-1.5M | ||
| Q1 25 | $4.6M | $-1.5M | ||
| Q4 24 | $6.1M | $-756.0K | ||
| Q3 24 | $4.5M | $1.7M | ||
| Q2 24 | $925.0K | $343.0K | ||
| Q1 24 | $1.9M | $-1.7M |
毛利率LCNBRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
营业利润率LCNBRMTI
| Q4 25 | 29.2% | -2.2% | ||
| Q3 25 | 35.6% | -9.9% | ||
| Q2 25 | 31.6% | -8.4% | ||
| Q1 25 | 25.6% | -7.2% | ||
| Q4 24 | 32.9% | -2.1% | ||
| Q3 24 | 24.9% | 6.8% | ||
| Q2 24 | 4.9% | 2.0% | ||
| Q1 24 | 12.5% | -5.8% |
净利率LCNBRMTI
| Q4 25 | 23.7% | -3.0% | ||
| Q3 25 | 29.1% | -11.0% | ||
| Q2 25 | 26.0% | -9.3% | ||
| Q1 25 | 21.4% | -8.0% | ||
| Q4 24 | 27.0% | -3.1% | ||
| Q3 24 | 21.2% | 5.9% | ||
| Q2 24 | 4.8% | 1.3% | ||
| Q1 24 | 10.7% | -7.6% |
每股收益（稀释后）LCNBRMTI
| Q4 25 | $0.40 | $-0.01 | ||
| Q3 25 | $0.49 | $-0.05 | ||
| Q2 25 | $0.41 | $-0.05 | ||
| Q1 25 | $0.33 | $-0.04 | ||
| Q4 24 | $0.44 | $-0.02 | ||
| Q3 24 | $0.31 | $0.04 | ||
| Q2 24 | $0.07 | $0.01 | ||
| Q1 24 | $0.15 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.6M | $10.7M |
| 总债务越低越好 | $104.4M | — |
| 股东权益账面价值 | $273.9M | $37.0M |
| 总资产 | $2.2B | $57.1M |
| 负债/权益比越低杠杆越低 | 0.38× | — |
8季度趋势，按日历期对齐
现金及短期投资LCNBRMTI
| Q4 25 | $21.6M | $10.7M | ||
| Q3 25 | $35.9M | $13.6M | ||
| Q2 25 | $49.8M | $12.5M | ||
| Q1 25 | $37.7M | $11.4M | ||
| Q4 24 | $35.7M | $15.7M | ||
| Q3 24 | $39.4M | $12.3M | ||
| Q2 24 | $34.9M | $11.9M | ||
| Q1 24 | $33.0M | $6.6M |
总债务LCNBRMTI
| Q4 25 | $104.4M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $105.0M | — | ||
| Q1 25 | $104.6M | — | ||
| Q4 24 | $155.2M | — | ||
| Q3 24 | $155.7M | — | ||
| Q2 24 | $162.2M | — | ||
| Q1 24 | $162.6M | — |
股东权益LCNBRMTI
| Q4 25 | $273.9M | $37.0M | ||
| Q3 25 | $269.9M | $37.0M | ||
| Q2 25 | $263.5M | $30.4M | ||
| Q1 25 | $258.7M | $31.5M | ||
| Q4 24 | $253.0M | $32.6M | ||
| Q3 24 | $253.2M | $29.1M | ||
| Q2 24 | $245.2M | $23.5M | ||
| Q1 24 | $233.7M | $20.6M |
总资产LCNBRMTI
| Q4 25 | $2.2B | $57.1M | ||
| Q3 25 | $2.2B | $57.5M | ||
| Q2 25 | $2.3B | $52.6M | ||
| Q1 25 | $2.3B | $54.0M | ||
| Q4 24 | $2.3B | $59.2M | ||
| Q3 24 | $2.3B | $57.1M | ||
| Q2 24 | $2.4B | $53.0M | ||
| Q1 24 | $2.3B | $50.7M |
负债/权益比LCNBRMTI
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.66× | — | ||
| Q1 24 | 0.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.4M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $33.4M | $2.2M |
| 自由现金流率自由现金流/营收 | 140.2% | 12.0% |
| 资本支出强度资本支出/营收 | 4.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 6.08× | — |
| 过去12个月自由现金流最近4个季度 | $54.5M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流LCNBRMTI
| Q4 25 | $34.4M | $2.3M | ||
| Q3 25 | $14.0M | $-1.3M | ||
| Q2 25 | $5.5M | $1.8M | ||
| Q1 25 | $2.2M | $-3.5M | ||
| Q4 24 | $93.2M | $865.0K | ||
| Q3 24 | $11.9M | $4.3M | ||
| Q2 24 | $54.9M | $1.4M | ||
| Q1 24 | $-11.9M | $-2.4M |
自由现金流LCNBRMTI
| Q4 25 | $33.4M | $2.2M | ||
| Q3 25 | $13.7M | $-1.5M | ||
| Q2 25 | $5.2M | $1.7M | ||
| Q1 25 | $2.1M | $-3.5M | ||
| Q4 24 | $89.4M | $470.0K | ||
| Q3 24 | $10.5M | $4.1M | ||
| Q2 24 | $53.8M | $1.2M | ||
| Q1 24 | $-12.8M | $-2.5M |
自由现金流率LCNBRMTI
| Q4 25 | 140.2% | 12.0% | ||
| Q3 25 | 57.4% | -9.6% | ||
| Q2 25 | 23.0% | 10.5% | ||
| Q1 25 | 10.0% | -18.8% | ||
| Q4 24 | 394.0% | 1.9% | ||
| Q3 24 | 49.0% | 14.4% | ||
| Q2 24 | 278.6% | 4.5% | ||
| Q1 24 | -71.8% | -11.1% |
资本支出强度LCNBRMTI
| Q4 25 | 4.0% | 0.5% | ||
| Q3 25 | 1.3% | 1.4% | ||
| Q2 25 | 1.0% | 1.0% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 16.7% | 1.6% | ||
| Q3 24 | 6.7% | 0.7% | ||
| Q2 24 | 5.9% | 1.1% | ||
| Q1 24 | 4.8% | 0.6% |
现金转化率LCNBRMTI
| Q4 25 | 6.08× | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 15.23× | — | ||
| Q3 24 | 2.63× | 2.57× | ||
| Q2 24 | 59.35× | 4.20× | ||
| Q1 24 | -6.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LCNB
暂无分部数据
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
